Monte Rosa Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4.2M | 2.8M | 12.8M | 23.2M | 84.9M | 60.6M | 9.2M | 4.7M |
| Cost of Goods Sold | 2.0M | 0 | 0 | 0 | 0 | 0 | 0 | 2.1M |
| Gross Profit | 2.2M | 2.8M | 12.8M | 23.2M | 84.9M | 60.6M | 9.2M | 2.6M |
| R&D Expenses | 44.1M | 42.0M | 36.7M | 30.7M | 32.2M | 38.9M | 27.6M | 26.0M |
| Operating Expenses | 52.2M | 52.5M | 45.7M | 38.7M | 40.9M | 47.6M | 35.7M | 35.3M |
| Operating Income | -50.0M | -49.7M | -33.0M | -15.6M | 44.0M | 13.0M | -26.5M | -32.6M |
| Other Income / Gains | 5.6M | 3.6M | 2.7M | 4.5M | 3.7M | 2.6M | 2.7M | 2.6M |
| Net Income | -44.5M | -46.1M | -27.1M | -12.3M | 46.9M | 13.4M | -23.9M | -30.3M |
| EPS (Diluted) | -0.68 | -0.70 | -0.33 | -0.15 | 0.57 | 0.22 | -0.29 | -0.43 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.518 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.561 |
| General And Administrative Expenses | 10.2M | 10.5M | 9.1M | 8.1M | 8.7M | 8.8M | 8.1M | 9.3M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 10.2M | 10.5M | 9.1M | 8.1M | 8.7M | 8.8M | 8.1M | 9.3M |
| Other Expenses | -2.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 54.2M | 52.5M | 45.7M | 38.7M | 40.9M | 47.6M | 35.7M | 37.3M |
| Interest Income | 5.6M | 3.7M | 2.7M | 3.1M | 3.4M | 2.6M | 2.9M | 2.6M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 2.0M | 2.1M | 2.1M | 2.1M | 2.0M | 2.1M | 2.1M | 2.1M |
| Ebitda | -42.4M | -44.0M | -28.2M | -9.0M | 49.8M | 17.7M | -21.7M | -28.0M |
| Ebitdaratio | -10.076 | -15.817 | -2.206 | -0.387 | 0.586 | 0.291 | -2.353 | -5.963 |
| Operating Income Ratio | -11.885 | -17.877 | -2.583 | -0.671 | 0.519 | 0.214 | -2.878 | -6.953 |
| Income Before Tax | -44.5M | -46.1M | -30.3M | -11.1M | 47.7M | 15.6M | -23.8M | -30.1M |
| Income Before Tax Ratio | -10.558 | -16.568 | -2.37 | -0.478 | 0.562 | 0.257 | -2.581 | -6.402 |
| Income Tax Expense | 52K | 59K | -3.2M | 1.2M | 822K | 2.2M | 71K | 252K |
| Net Income Ratio | -10.571 | -16.589 | -2.121 | -0.53 | 0.552 | 0.222 | -2.589 | -6.456 |
| Epsdiluted | -0.68 | -0.70 | -0.33 | -0.15 | 0.57 | 0.22 | -0.29 | -0.43 |
| Weighted Average Shs Out | 65.5M | 65.5M | 82.4M | 82.2M | 82.1M | 61.4M | 82.0M | 71.2M |
| Weighted Average Shs Out Dil | 65.5M | 65.5M | 82.4M | 82.2M | 83.0M | 61.4M | 82.0M | 71.2M |